STRATA Skin Sciences, Inc. (SSKN)
OTCMKTS
· Delayed Price · Currency is USD
0.270
+0.010 (3.85%)
At close: Mar 6, 2026
STRATA Skin Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 30.98 | 33.56 | 33.36 | 36.16 | 29.98 | 23.09 | Upgrade
|
| Revenue Growth (YoY) | -5.19% | 0.61% | -7.75% | 20.63% | 29.83% | -26.90% | Upgrade
|
| Cost of Revenue | 13.09 | 14.48 | 14.9 | 14.39 | 10.13 | 8.96 | Upgrade
|
| Gross Profit | 17.89 | 19.08 | 18.46 | 21.77 | 19.85 | 14.13 | Upgrade
|
| Selling, General & Admin | 23.63 | 23.59 | 23.46 | 25.39 | 22.82 | 16.94 | Upgrade
|
| Research & Development | 0.55 | 0.88 | 1.32 | 1.03 | 1.43 | 1.27 | Upgrade
|
| Operating Expenses | 24.19 | 24.48 | 24.78 | 26.42 | 24.25 | 18.21 | Upgrade
|
| Operating Income | -6.3 | -5.39 | -6.32 | -4.65 | -4.4 | -4.08 | Upgrade
|
| Interest Expense | -1.99 | -2.11 | -1.64 | -0.93 | -0.31 | -0.21 | Upgrade
|
| Interest & Investment Income | 0.42 | 0.24 | 0.23 | 0.09 | 0.02 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | -7.87 | -7.26 | -7.73 | -5.49 | -4.7 | -4.14 | Upgrade
|
| Impairment of Goodwill | -3.86 | -3.86 | -2.28 | - | - | - | Upgrade
|
| Other Unusual Items | 0.68 | 0.86 | -0.91 | - | 2.03 | - | Upgrade
|
| Pretax Income | -11.04 | -10.26 | -10.92 | -5.49 | -2.67 | -4.14 | Upgrade
|
| Income Tax Expense | -0.17 | -0.17 | -0.09 | 0.06 | 0.03 | 0.28 | Upgrade
|
| Net Income | -10.87 | -10.09 | -10.83 | -5.55 | -2.71 | -4.41 | Upgrade
|
| Net Income to Common | -10.87 | -10.09 | -10.83 | -5.55 | -2.71 | -4.41 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 16.79% | 9.03% | 0.60% | 1.94% | 1.31% | 5.09% | Upgrade
|
| EPS (Basic) | -2.56 | -2.65 | -3.10 | -1.60 | -0.79 | -1.31 | Upgrade
|
| EPS (Diluted) | -2.56 | -2.65 | -3.10 | -1.60 | -0.79 | -1.31 | Upgrade
|
| Free Cash Flow | -3.51 | -1.45 | -5.54 | -4.66 | -2.15 | -0.06 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -0.38 | -1.59 | -1.34 | -0.63 | -0.02 | Upgrade
|
| Gross Margin | 57.74% | 56.85% | 55.34% | 60.20% | 66.22% | 61.21% | Upgrade
|
| Operating Margin | -20.32% | -16.07% | -18.95% | -12.86% | -14.69% | -17.65% | Upgrade
|
| Profit Margin | -35.10% | -30.05% | -32.47% | -15.35% | -9.03% | -19.11% | Upgrade
|
| Free Cash Flow Margin | -11.34% | -4.31% | -16.60% | -12.89% | -7.16% | -0.27% | Upgrade
|
| EBITDA | -1.76 | -0.43 | -0.77 | 0.64 | -0.67 | -0.49 | Upgrade
|
| EBITDA Margin | -5.69% | -1.27% | -2.30% | 1.78% | -2.22% | -2.13% | Upgrade
|
| D&A For EBITDA | 4.53 | 4.97 | 5.55 | 5.29 | 3.74 | 3.59 | Upgrade
|
| EBIT | -6.3 | -5.39 | -6.32 | -4.65 | -4.4 | -4.08 | Upgrade
|
| EBIT Margin | -20.32% | -16.07% | -18.95% | -12.86% | -14.68% | -17.65% | Upgrade
|
| Advertising Expenses | - | 1 | 0.5 | 1.6 | 1.6 | 0.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.